Nav1.7-targeting antisense oligonucleotide (Q-State Biosciences)

N/A

Report date: 2025/03/14 16:18:54
NME

Base Information

Drug NameNav1.7-targeting antisense oligonucleotide (Q-State Biosciences)
Drug Alias NameNav1.7-targeting ASO (Q-State Biosciences)antisense oligonucleotide (Q-State Biosciences)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsCancer PainPainRadiculopathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiver Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuiver Bioscience Inc
Inactive CompaniesN/A
Active IndicationsCancer PainPainRadiculopathy
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A